{"id":389895,"date":"2020-11-30T16:08:09","date_gmt":"2020-11-30T21:08:09","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=389895"},"modified":"2020-11-30T16:08:09","modified_gmt":"2020-11-30T21:08:09","slug":"baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\/","title":{"rendered":"Baudax Bio to Participate in the Piper Sandler 32nd Annual Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">MALVERN, Pa., Nov.  30, 2020  (GLOBE NEWSWIRE) &#8212; Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that Gerri Henwood, the Company\u2019s President and Chief Executive Officer, will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference, being held virtually December 1-3, 2020. The company will conduct institutional investor meetings on December 2, 2020; meetings may be requested through Piper Sandler.<\/p>\n<p align=\"justify\">A pre-recorded fireside chat with Ms. Henwood is now available on the Piper Sandler conference site and on the \u201cEvents\u201d page within the Investors section of the Baudax Bio website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PVkVKeltZe77YRn2eDK9svmHOUtQpSMyqij9AzFSKjLT61c5GCK45QmaoTdGimtDH-ukuKSeudIPHY5KtN39LoSJDQ5fjrGN1DGOnRTFOfyQ_1FwpZCYiYVDp0yH5MrcJbC2rXjfsYgMlHWqHYhmCA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/www.baudaxbio.com\/news-and-investors<\/a>. The recording will be available for a period of 30 days following the event.<\/p>\n<p align=\"justify\">\n        <strong>About Baudax Bio<\/strong>\n      <\/p>\n<p align=\"justify\">Baudax Bio is a pharmaceutical company focused on therapeutics for acute care settings. The launch of Baudax Bio\u2019s first commercial product ANJESO<sup>\u00ae<\/sup> began in June 2020 following its approval by the U.S. Food and Drug Administration in February 2020. ANJESO is a once daily IV NSAID with preferential COX-2 activity, which has successfully completed three Phase III clinical trials, including two pivotal efficacy trials, a large double-blind Phase III safety trial and other studies for the management of moderate to severe pain. In addition to ANJESO, Baudax has a pipeline of other pharmaceutical assets including two novel neuromuscular blocking agents (NMBAs) and a proprietary chemical reversal agent specific to these NMBAs which is currently in preclinical studies, and intranasal dexmedetomidine which is being developed for possible uses in pain or sedation. For more information please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9agUkBiWrhlmDyD957TdLKalkfMZ1_EKBOexdYKNP9UoI2LTrw9RDIM2Q_FummBcAYvf9GwqcBuuqlvv8HXUag==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.baudaxbio.com<\/a>.<\/p>\n<p>\n        <strong>CONTACT:<\/strong>\n      <\/p>\n<p>\n        <strong>Investor Relations Contact:<\/strong><br \/>\n        <br \/>Argot Partners<br \/>Sam Martin \/ Claudia Styslinger<br \/>(212) 600-1902<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nD-elhmiuUqUpN-PwFpjsBtDiQJPm6HeFSGFT22GmbOfSeM8n8sWpiMABNKlWU1Rm0Z3dZdFUYDBBHyll2YJ_3N15Wv6cUuXU4Lxwl5_zpc=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">sam@argotpartners.com<\/a><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=H8KSx3k3DqqrboQZpmRFH2n4NyOYg_T69kQ0Ved3vzyA-p6SKQV89cLgDf111MCF1pObXxmhc7-ZASoK7gSt8GPet7atCMqKYbFB0actQrs=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">claudia@argotpartners.com<\/a><\/p>\n<p>\n        <strong>Baudax Bio, Inc.<\/strong><br \/>\n        <br \/>Ryan D. Lake<br \/>(484) 395-2436<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OGb2K06Lw1gHrZjx9blf6nsqAiF5WYlcLZfha92FCZTxza3ScjUh2id9c0Q2a9DAGjnMhFACbgvYRV4au6RErx1xnHlD9tEfSNWNd0bIF2Q=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">rlake@baudaxbio.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Argot Partners<br \/>David Rosen<br \/>(212) 600-1902<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HyY0CDm-mkNuAFtUJz0dRkhSiRfBJU2f20ACpHQ_oYBAqs20qvkf3CVsaUXvxbfUuWMV0_g4mEvOJtr909NlPqP4U2cu8tNJz4wknBq_X3bo8bWyGjqXQIhxWG7JIrcv\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">david.rosen@argotpartners.com<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NDAwMSMzODQ4NzIyIzIxOTM0NDI=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/9afbc19e-bcd8-4456-a3ae-98d4577dac81\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MALVERN, Pa., Nov. 30, 2020 (GLOBE NEWSWIRE) &#8212; Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that Gerri Henwood, the Company\u2019s President and Chief Executive Officer, will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference, being held virtually December 1-3, 2020. The company will conduct institutional investor meetings on December 2, 2020; meetings may be requested through Piper Sandler. A pre-recorded fireside chat with Ms. Henwood is now available on the Piper Sandler conference site and on the \u201cEvents\u201d page within the Investors section of the Baudax Bio website at https:\/\/www.baudaxbio.com\/news-and-investors. The recording will be available for a period of 30 days following the event. About Baudax Bio Baudax Bio &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Baudax Bio to Participate in the Piper Sandler 32nd Annual Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-389895","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Baudax Bio to Participate in the Piper Sandler 32nd Annual Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Baudax Bio to Participate in the Piper Sandler 32nd Annual Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MALVERN, Pa., Nov. 30, 2020 (GLOBE NEWSWIRE) &#8212; Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that Gerri Henwood, the Company\u2019s President and Chief Executive Officer, will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference, being held virtually December 1-3, 2020. The company will conduct institutional investor meetings on December 2, 2020; meetings may be requested through Piper Sandler. A pre-recorded fireside chat with Ms. Henwood is now available on the Piper Sandler conference site and on the \u201cEvents\u201d page within the Investors section of the Baudax Bio website at https:\/\/www.baudaxbio.com\/news-and-investors. The recording will be available for a period of 30 days following the event. About Baudax Bio Baudax Bio &hellip; Continue reading &quot;Baudax Bio to Participate in the Piper Sandler 32nd Annual Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-30T21:08:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NDAwMSMzODQ4NzIyIzIxOTM0NDI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Baudax Bio to Participate in the Piper Sandler 32nd Annual Healthcare Conference\",\"datePublished\":\"2020-11-30T21:08:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\\\/\"},\"wordCount\":305,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NDAwMSMzODQ4NzIyIzIxOTM0NDI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\\\/\",\"name\":\"Baudax Bio to Participate in the Piper Sandler 32nd Annual Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NDAwMSMzODQ4NzIyIzIxOTM0NDI=\",\"datePublished\":\"2020-11-30T21:08:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NDAwMSMzODQ4NzIyIzIxOTM0NDI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NDAwMSMzODQ4NzIyIzIxOTM0NDI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Baudax Bio to Participate in the Piper Sandler 32nd Annual Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Baudax Bio to Participate in the Piper Sandler 32nd Annual Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Baudax Bio to Participate in the Piper Sandler 32nd Annual Healthcare Conference - Market Newsdesk","og_description":"MALVERN, Pa., Nov. 30, 2020 (GLOBE NEWSWIRE) &#8212; Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that Gerri Henwood, the Company\u2019s President and Chief Executive Officer, will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference, being held virtually December 1-3, 2020. The company will conduct institutional investor meetings on December 2, 2020; meetings may be requested through Piper Sandler. A pre-recorded fireside chat with Ms. Henwood is now available on the Piper Sandler conference site and on the \u201cEvents\u201d page within the Investors section of the Baudax Bio website at https:\/\/www.baudaxbio.com\/news-and-investors. The recording will be available for a period of 30 days following the event. About Baudax Bio Baudax Bio &hellip; Continue reading \"Baudax Bio to Participate in the Piper Sandler 32nd Annual Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-30T21:08:09+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NDAwMSMzODQ4NzIyIzIxOTM0NDI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Baudax Bio to Participate in the Piper Sandler 32nd Annual Healthcare Conference","datePublished":"2020-11-30T21:08:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\/"},"wordCount":305,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NDAwMSMzODQ4NzIyIzIxOTM0NDI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\/","name":"Baudax Bio to Participate in the Piper Sandler 32nd Annual Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NDAwMSMzODQ4NzIyIzIxOTM0NDI=","datePublished":"2020-11-30T21:08:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NDAwMSMzODQ4NzIyIzIxOTM0NDI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NDAwMSMzODQ4NzIyIzIxOTM0NDI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baudax-bio-to-participate-in-the-piper-sandler-32nd-annual-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Baudax Bio to Participate in the Piper Sandler 32nd Annual Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/389895","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=389895"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/389895\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=389895"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=389895"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=389895"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}